286 related articles for article (PubMed ID: 22919247)
21. Differentiation of pancreatobiliary cancer from benign biliary strictures using neutrophil gelatinase-associated lipocalin.
Budzynska A; Nowakowska-Dulawa E; Marek T; Boldys H; Nowak A; Hartleb M
J Physiol Pharmacol; 2013 Feb; 64(1):109-14. PubMed ID: 23568978
[TBL] [Abstract][Full Text] [Related]
22. Clinical values of CA19-9, CA125 and CEA in malignant obstructive jaundice.
Ng WW; Tong KJ; Tam TN; Lee SD
Zhonghua Yi Xue Za Zhi (Taipei); 1995 Jun; 55(6):438-46. PubMed ID: 7634181
[TBL] [Abstract][Full Text] [Related]
23. [CA19-9 has no value as a tumor marker in obstructive jaundice].
Peterli R; Meyer-Wyss B; Herzog U; Tondelli P
Schweiz Med Wochenschr; 1999 Jan; 129(3):77-9. PubMed ID: 10065510
[TBL] [Abstract][Full Text] [Related]
24. Elevation of carbohydrate antigen 19.9 in benign hepatobiliary conditions and its correlation with serum bilirubin concentration.
Ong SL; Sachdeva A; Garcea G; Gravante G; Metcalfe MS; Lloyd DM; Berry DP; Dennison AR
Dig Dis Sci; 2008 Dec; 53(12):3213-7. PubMed ID: 18465243
[TBL] [Abstract][Full Text] [Related]
25. [Comparison of the therapeutic effects of PTBD and PTBS in treatment of malignant obstructive jaundice].
Bai AG; Zheng CS; Zhou GF; Liang HM; Feng GS
Zhonghua Zhong Liu Za Zhi; 2010 Jun; 32(6):456-8. PubMed ID: 20819490
[TBL] [Abstract][Full Text] [Related]
26. Proposed cut-off value of CA19-9 for detecting pancreatic cancer in patients with diabetes: a case-control study.
Murakami M; Nagai Y; Tenjin A; Tanaka Y
Endocr J; 2018 Jun; 65(6):639-643. PubMed ID: 29643268
[TBL] [Abstract][Full Text] [Related]
27. Clinical significance of serum tumour M2-PK and CA19-9 detection in the diagnosis of cholangiocarcinoma.
Li YG; Zhang N
Dig Liver Dis; 2009 Aug; 41(8):605-8. PubMed ID: 19168405
[TBL] [Abstract][Full Text] [Related]
28. Transhepatic forceps biopsy combined with biliary drainage in obstructive jaundice: safety and accuracy.
Fohlen A; Bazille C; Menahem B; Jegonday MA; Dupont B; Le Pennec V; Lubrano J; Guiu B; Pelage JP
Eur Radiol; 2019 May; 29(5):2426-2435. PubMed ID: 30511177
[TBL] [Abstract][Full Text] [Related]
29. Application of Joint Detection of AFP, CA19-9, CA125 and CEA in Identification and Diagnosis of Cholangiocarcinoma.
Li Y; Li DJ; Chen J; Liu W; Li JW; Jiang P; Zhao X; Guo F; Li XW; Wang SG
Asian Pac J Cancer Prev; 2015; 16(8):3451-5. PubMed ID: 25921161
[TBL] [Abstract][Full Text] [Related]
30. C-reactive protein is a prognostic indicator in patients with perihilar cholangiocarcinoma.
Gerhardt T; Milz S; Schepke M; Feldmann G; Wolff M; Sauerbruch T; Dumoulin FL
World J Gastroenterol; 2006 Sep; 12(34):5495-500. PubMed ID: 17006987
[TBL] [Abstract][Full Text] [Related]
31. Total serum bile acid as a potential marker for the diagnosis of cholangiocarcinoma without jaundice.
Sombattheera S; Proungvitaya T; Limpaiboon T; Wongkham S; Wongkham C; Luvira V; Proungvitaya S
Asian Pac J Cancer Prev; 2015; 16(4):1367-70. PubMed ID: 25743800
[TBL] [Abstract][Full Text] [Related]
32. Bilirubin levels predict malignancy in patients with obstructive jaundice.
Garcea G; Ngu W; Neal CP; Dennison AR; Berry DP
HPB (Oxford); 2011 Jun; 13(6):426-30. PubMed ID: 21609376
[TBL] [Abstract][Full Text] [Related]
33. Investigation of Factors Affecting the Sensitivity of Bile Duct Brush Cytology.
Kobayashi M; Ryozawa S; Araki R; Nagata K; Tanisaka Y; Fujita A; Kobatake T
Intern Med; 2019 Feb; 58(3):329-335. PubMed ID: 30146607
[TBL] [Abstract][Full Text] [Related]
34. A rare cause of obstructive jaundice: Fasciola hepatica mimicking cholangiocarcinoma.
Yalav O; Yağmur Ö; Ülkü A; Akcam AT; Sönmez H
Turk J Gastroenterol; 2012; 23(5):604-7. PubMed ID: 23161310
[TBL] [Abstract][Full Text] [Related]
35. Prognostic relevance of preoperative bilirubin-adjusted serum carbohydrate antigen 19-9 in a multicenter subset analysis of 179 patients with distal cholangiocarcinoma.
Bolm L; Petrova E; Weitz J; Rückert F; Wittel UA; Makowiec F; Lapshyn H; Bronsert P; Rau BM; Khatkov IE; Bausch D; Keck T; Wellner UF; Distler M
HPB (Oxford); 2019 Nov; 21(11):1513-1519. PubMed ID: 30956162
[TBL] [Abstract][Full Text] [Related]
36. Comparison of preoperative serum CA19-9 levels with results of diagnostic imaging modalities in patients undergoing laparotomy for suspected pancreatic or gallbladder disease.
Ritts RE; Nagorney DM; Jacobsen DJ; Talbot RW; Zurawski VR
Pancreas; 1994 Nov; 9(6):707-16. PubMed ID: 7846013
[TBL] [Abstract][Full Text] [Related]
37. Aetiological spectrum of obstructive jaundice and diagnostic ability of ultrasonography: a clinician's perspective.
Sharma MP; Ahuja V
Trop Gastroenterol; 1999; 20(4):167-9. PubMed ID: 10769604
[TBL] [Abstract][Full Text] [Related]
38. [Effect of preoperative biliary drainage on liver function changes in patients with malignant obstructive jaundice in the low bile duct before and after pancreaticoduodenectomy].
Chen D; Liang LJ; Peng BG; Zhou Q; Li SQ; Tang D; Huang L; Huang JF
Ai Zheng; 2008 Jan; 27(1):78-82. PubMed ID: 18184470
[TBL] [Abstract][Full Text] [Related]
39. Pancreatic cancer and predictors of survival: comparing the CA 19-9/bilirubin ratio with the McGill Brisbane Symptom Score.
Dumitra S; Jamal MH; Aboukhalil J; Doi SA; Chaudhury P; Hassanain M; Metrakos PP; Barkun JS
HPB (Oxford); 2013 Dec; 15(12):1002-9. PubMed ID: 23521164
[TBL] [Abstract][Full Text] [Related]
40. Preoperative carbohydrate antigen 19-9 is most predictive of malignancy in older jaundiced patients undergoing pancreatic resection.
Bloomston M; Bekaii-Saab TS; Kosuri K; Cowgill SM; Melvin WS; Ellison EC; Muscarella P
Pancreas; 2006 Oct; 33(3):246-9. PubMed ID: 17003645
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
